Breakthrough Genomics is a leader in the clinical interpretation of genomic data.
The company operates a CAP and CLIA-certified genomics lab to provide cutting-edge tests for genetic risk assessment, rare disease diagnosis, and early cancer detection.
The mission of the company is to improve access to advanced life-saving tests and precision medicine both in the U.S. and around the world.

Clinical Genomics in USA | BT Genomics

Welcome to Breakthrough Genomics

By combining next generation computing power with the clinical expertise of a certified CAP/CLIA lab, Breakthrough Genomics tests deliver high diagnostic yields with fast turnaround times.

Breakthrough Genomics works with healthcare providers, research institutions, and partner organizations to provide genetic tests both in the U.S. and around the world.

LEARN MORE ABOUT BREAKTHROUGH GENOMICS

KNOWN GENETIC VARIANTS

SCIENTIFIC PUBLICATIONS SCANNED

SAMPLES PROCESSED

Our Services

- Advanced Genetic Tests
  Breakthrough Genomics offers a wide range of advanced genetic tests from hereditary cancer and cardiovascular screening to rare disease diagnosis and rapid Whole Genome and Whole Exome tests for the NICU and PICU.
- Early Cancer Detections
  The company’s early cancer detection tests revolutionize screening for a range of cancers, including pancreatic cancer, colon cancer, stomach cancer, liver cancer, and more, using just a simple tube of blood. These tests have received prestigious recognition, including the FDA Breakthrough Device grant and the EU IVDD certificate.
- Clinical Genomic Analysis with Next-Generation Computing
  Breakthrough Genomics leverages the company’s proprietary technology and hands-on experience in clinical genomics to help solve the biggest challenges
  in precision medicine.